Volibose Trio 2mg/500mg/0.2mg Tablet
Marketer
Saan Labs
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Volibose Trio 2mg/500mg/0.2mg Tablet
Triginta-Diabetics 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes mellitus, effectively managing blood glucose control. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to identify its symptoms—sweating, dizziness, headache, and tremors—and how to manage them. Maintain regular mealtimes and carry a fast-acting glucose source, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Patients with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.
Uses of Volibose Trio 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Volibose Trio 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire Volibose Trio 2mg/500mg/0.2mg tablet without chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Volibose Trio 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Volibose Trio 2mg/500mg/0.2mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Volibose Trio 2mg/500mg/0.2mg tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
How Volibose Trio 2mg/500mg/0.2mg Tablet works:
The tablet Volibose Trio (2mg/500mg/0.2mg) combines three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Volibose Trio 2mg/500mg/0.2mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Volibose Trio 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Use of Volibose Trio 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Volibose Trio 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Patients with severe kidney disease are strongly advised against its use; physician consultation is recommended.
LiverCAUTION
Patients with liver disease should use Volibose Trio 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Consult a physician. In patients with mild to moderate liver impairment, initiate treatment with a low dose; however, the medication is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Volibose Trio 2mg/500mg/0.2mg Tablet :
Should you forget to take a Volibose Trio 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Volibose Trio 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently